Zobrazeno 1 - 10
of 506
pro vyhledávání: '"Allan H, Friedman"'
Autor:
Suseendrakumar Duraivel, Shervin Rahimpour, Chia-Han Chiang, Michael Trumpis, Charles Wang, Katrina Barth, Stephen C. Harward, Shivanand P. Lad, Allan H. Friedman, Derek G. Southwell, Saurabh R. Sinha, Jonathan Viventi, Gregory B. Cogan
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Patients suffering from debilitating neurodegenerative diseases often lose the ability to communicate, detrimentally affecting their quality of life. One solution to restore communication is to decode signals directly from the brain to enabl
Externí odkaz:
https://doaj.org/article/145648d56b284884badee79ef4520f18
Autor:
Collin L. Kent, MD, Yvonne M. Mowery, MD, PhD, Olayode Babatunde, MD, Ato O. Wright, MD, Ian Barak, MS, Frances McSherry, MA, James E. Herndon, II, PhD, Allan H. Friedman, MD, Ali Zomorodi, MD, Katherine Peters, MD, PhD, Annick Desjardins, MD, Henry Friedman, MD, William Sperduto, MBS, John P. Kirkpatrick, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 3, Pp 100878- (2022)
Purpose: Atypical (World Health Organization [WHO] grade 2) and malignant (WHO grade 3) meningiomas have high rates of local recurrence, and questions remain about the role of adjuvant radiation therapy (RT) for patients with WHO grade 2 disease. The
Externí odkaz:
https://doaj.org/article/109b243dcbdf431489d044ba13f65cea
Autor:
Matthias Gromeier, Michael C. Brown, Gao Zhang, Xiang Lin, Yeqing Chen, Zhi Wei, Nike Beaubier, Hai Yan, Yiping He, Annick Desjardins, James E. Herndon, Frederick S. Varn, Roel G. Verhaak, Junfei Zhao, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea M. Muscat, Eric S. Lipp, Smita K. Nair, Mustafa Khasraw, Katherine B. Peters, Dina Randazzo, John H. Sampson, Roger E. McLendon, Darell D. Bigner, David M. Ashley
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Recurrent glioblastomas (rGBM) have dismal outcomes, but long-term survival has been observed in subsets of patients after immunotherapy. Here the authors report a positive association between low tumor mutation burden, inflammatory gene signatures,
Externí odkaz:
https://doaj.org/article/9b4f7304b8f54613b5f0b6626698e589
Autor:
Bill H. Diplas, Xujun He, Jacqueline A. Brosnan-Cashman, Heng Liu, Lee H. Chen, Zhaohui Wang, Casey J. Moure, Patrick J. Killela, Daniel B. Loriaux, Eric S. Lipp, Paula K. Greer, Rui Yang, Anthony J. Rizzo, Fausto J. Rodriguez, Allan H. Friedman, Henry S. Friedman, Sizhen Wang, Yiping He, Roger E. McLendon, Darell D. Bigner, Yuchen Jiao, Matthew S. Waitkus, Alan K. Meeker, Hai Yan
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Glioblastoma can be classified based on IDH and TERT promoter mutations, but ~20% of glioblastoma do not have these mutations (TERT p WT-IDH WT glioblastoma). Here, the authors present a genetic landscape of TERTp WT-IDH WT glioblastoma, identifying
Externí odkaz:
https://doaj.org/article/dd48eac540f1490a9bb31a4f740711ca
Autor:
Takuro, Inoue, Yukihiro, Goto, Satoshi, Shitara, Ryan, Keswani, Mustaqim, Prasetya, Abrar, Arham, Kenichiro, Kikuta, Lori, Radcliffe, Allan H, Friedman, Takanori, Fukushima
Publikováno v:
Acta Neurochirurgica. 164:3235-3246
A thorough observation of the root exit zone (REZ) and secure transposition of the offending arteries is crucial for a successful microvascular decompression (MVD) for hemifacial spasm (HFS). Decompression procedures are not always feasible in a narr
Autor:
John H. Sampson, Duane A. Mitchell, Gordana Vlahovic, Darell Bigner, Henry S. Friedman, Allan H. Friedman, Roger E. McLendon, Patrick Healy, James E. Herndon, Weihua Xie, Pam Norberg, Robert J. Schmittling, Smita K. Nair, Luis Sanchez-Perez, Gary E. Archer, Elizabeth A. Reap, Kristen A. Batich
supplementary figures and legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5fcb114cba3c65477708b3f9a182cf
https://doi.org/10.1158/1078-0432.22467126
https://doi.org/10.1158/1078-0432.22467126
Autor:
John H. Sampson, Duane A. Mitchell, Peter E. Fecci, Darell D. Bigner, Henry S. Friedman, Allan H. Friedman, Roger E. McLendon, Gordana Vlahovic, Annick Desjardins, Kent J. Weinhold, Taylor M. Broome, Anastasie M. Dunn-Pirio, Smita K. Nair, Anirudh Saraswathula, Mohammed K. Hossain-Ibrahim, John S. Yi, Katherine A. Riccione, Adam M. Swartz, Olivia C. Campbell, Patrick C. Gedeon, Kendra L. Congdon, Patrick Healy, James E. Herndon, Pamela K. Norberg, Robert J. Schmittling, Gary E. Archer, Luis Sanchez-Perez, Kristen A. Batich, Carter M. Suryadevara, Elizabeth A. Reap
Summary of adverse events with possible relation to study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6d423c21966ce90fefe65599e1ca46
https://doi.org/10.1158/0008-5472.22417785.v1
https://doi.org/10.1158/0008-5472.22417785.v1
Autor:
John H. Sampson, Duane A. Mitchell, Peter E. Fecci, Darell D. Bigner, Henry S. Friedman, Allan H. Friedman, Roger E. McLendon, Gordana Vlahovic, Annick Desjardins, Kent J. Weinhold, Taylor M. Broome, Anastasie M. Dunn-Pirio, Smita K. Nair, Anirudh Saraswathula, Mohammed K. Hossain-Ibrahim, John S. Yi, Katherine A. Riccione, Adam M. Swartz, Olivia C. Campbell, Patrick C. Gedeon, Kendra L. Congdon, Patrick Healy, James E. Herndon, Pamela K. Norberg, Robert J. Schmittling, Gary E. Archer, Luis Sanchez-Perez, Kristen A. Batich, Carter M. Suryadevara, Elizabeth A. Reap
Ex vivo analysis of CMV pp65-specific CD8+ T cells in circulation before and after immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ddd773de4481cf84d8cddf24412e18
https://doi.org/10.1158/0008-5472.22417791.v1
https://doi.org/10.1158/0008-5472.22417791.v1
Autor:
James J. Vredenburgh, Henry S. Friedman, Allan H. Friedman, Darell D. Bigner, Leighann Bailey, John Sampson, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, Jennifer A. Quinn, Jennifer Marcello, James E. Herndon, David A. Reardon, Annick Desjardins
Purpose: Although patients with newly diagnosed WHO grade 3 malignant glioma have a more favorable prognosis than those with WHO grade 4 malignant glioma, salvage therapies following recurrence offer essentially palliative benefit. We did a phase II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bc4c8b61c92c61495b258cf356c5f5
https://doi.org/10.1158/1078-0432.c.6516909.v1
https://doi.org/10.1158/1078-0432.c.6516909.v1
Autor:
James J. Vredenburgh, Henry S. Friedman, Allan H. Friedman, Darell D. Bigner, Leighann Bailey, John Sampson, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, Jennifer A. Quinn, Jennifer Marcello, James E. Herndon, David A. Reardon, Annick Desjardins
Supplementary Table S3 from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0459b1c579da6e8c393e3f710f991df
https://doi.org/10.1158/1078-0432.22439439.v1
https://doi.org/10.1158/1078-0432.22439439.v1